Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6117296 | Immunology Letters | 2014 | 6 Pages |
Abstract
CXCL8, CXCL10, CXCL11, CXCL12, CXCL13 are involved in the pathomechanism of NB but their role is different in s and csf. CXCL13 seems to be a good biomarker for NB. In early NB, it may facilitate the diagnosis and monitoring of therapy. However tick-borne encephalitis needs to be excluded as it also increases chemokine concentration. Decrease in all examined chemokines in s and csf after treatment suggests that chemokines may be useful in monitoring response to NB therapy.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Anna Moniuszko, Piotr Czupryna, SÅawomir Pancewicz, Krzysztof Rutkowski, Olga Zajkowska, Renata ÅwierzbiÅska, Sambor Grygorczuk, Maciej Kondrusik, Piotr OwÅasiuk, Joanna Zajkowska,